IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
200.60
-0.26 (-0.13%)
At close: Oct 8, 2025, 4:00 PM EDT
204.61
+4.01 (2.00%)
After-hours: Oct 8, 2025, 7:22 PM EDT
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $4.02B in the quarter ending June 30, 2025, with 5.32% growth. This brings the company's revenue in the last twelve months to $15.70B, up 3.60% year-over-year. In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth.
Revenue (ttm)
$15.70B
Revenue Growth
+3.60%
P/S Ratio
2.26
Revenue / Employee
$178,409
Employees
88,000
Market Cap
34.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
IQV News
- 8 days ago - IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025 - Business Wire
- 12 days ago - ILMN Stock vs. IQV Stock - Forbes
- 22 days ago - IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships - Business Wire
- 4 weeks ago - IQVIA: A Positive Long-Term Outlook Despite Trump Legislation - Seeking Alpha
- 4 weeks ago - IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management - Business Wire
- 5 weeks ago - IQVIA names Michael Fedock as financial chief - Reuters
- 5 weeks ago - IQVIA Announces CFO Transition in Early 2026 - Business Wire
- 5 weeks ago - IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies - PRNewsWire